UK consensus on pre-clinical vascular cognitive impairment functional outcomes assessment: questionnaire and workshop proceedings

Aisling McFall, Tuuli M. Hietamies, Ashton Bernard, Margaux Aimable, Stuart M. Allan, Philip M. Bath, Gaia Brezzo, Roxana O. Carare, Hilary V. Carswell, Andrew N. Clarkson, Gillian Currie, Tracy D. Farr, Jill Fowler, Mark Good, Atticus H. Hainsworth, Catherine Hall, Karen Horsburgh, Rajesh Kalaria, Patrick Kehoe, Catherine LawrenceMalcolm Macleod, Alison McNeilly, Alyson A. Miller, Scott Miners, Vincent Mok, Michael O’Sullivan, Bettina Platt, Emily S. Sena, Matthew Sharp, Patrick Strangeward, Stefan Szymkowiak, Rhian M. Touyz, Rebecca C. Trueman, Claire White, Chris McCabe, Lorraine M. Work* (Corresponding Author), Terence J. Quinn

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)
8 Downloads (Pure)

Abstract

Assessment of outcome in preclinical studies of vascular cognitive impairment (VCI) is heterogenous. Through an ARUK Scottish Network supported questionnaire and workshop (mostly UK-based researchers), we aimed to determine underlying variability and what could be implemented to overcome identified challenges. Twelve UK VCI research centres were identified and invited to complete a questionnaire and attend a one-day workshop. Questionnaire responses demonstrated agreement that outcome assessments in VCI preclinical research vary by group and even those common across groups, may be performed differently. From the workshop, 6 themes were discussed: issues with preclinical models, reasons for choosing functional assessments, issues in interpretation of functional assessments, describing and reporting functional outcome assessments, sharing resources and expertise, and standardization of outcomes. Eight consensus points emerged demonstrating broadly that the chosen assessment should reflect the deficit being measured and therefore, that one assessment does not suit all models; guidance/standardisation on recording VCI outcome reporting is needed and that uniformity would be aided by a platform to share expertise, material, protocols and procedures thus reducing heterogeneity and so increasing potential for collaboration, comparison and replication. As a result of the workshop, UK wide consensus statements were agreed and future priorities for preclinical research identified.
Original languageEnglish
Pages (from-to)1402-1414
Number of pages13
JournalJournal of Cerebral Blood Flow and Metabolism
Volume40
Issue number7
Early online date9 Mar 2020
DOIs
Publication statusPublished - Jul 2020

Bibliographical note

FUNDING: The workshop was supported through an ARUK Scottish Network small grant. PMB is Stroke Association Professor, Stroke Medicine and a NIHR Senior Investigator. Several of the authors are members of the Dementias Platform UK Vascular experimental medicine group (AHH, KH, RC, RNK, SMA, TJQ). AMcF is supported by a BHF PhD studentship (FS/15/64/32035) and TMH a Cunningham Trust PhD studentship (CU15007.0001).

ACKNOWLEDGEMENTS: We are grateful to the Institute of Cardiovascular and Medical Sciences, University of Glasgow for hosting the meeting.

Keywords

  • dementia
  • methodology
  • outcomes
  • questionnaire
  • vascular cognitive impairment
  • Dementia
  • TRIALS
  • DEMENTIA
  • NINDS
  • STROKE
  • MODELS
  • DISEASE
  • REHABILITATION

Fingerprint

Dive into the research topics of 'UK consensus on pre-clinical vascular cognitive impairment functional outcomes assessment: questionnaire and workshop proceedings'. Together they form a unique fingerprint.

Cite this